Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9

참고문헌 (68)

1. Sharma, R., "Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials", Sci. Rep, 11, pp.2189~ (2021)
2. Tang, X., "Wound healing driver gene and therapeutic development: political and scientific hurdles", Adv. Wound Care (N. Rochelle), 10, pp.415~435 (2021)
3. Simon Matoori, "Advanced bandages for diabetic wound healing", Science Translational Medicine, 13(585) (2021), American Association for the Advancement of Science (AAAS)[DOI]
4. Jeffcoate, W. J., "Current challenges and opportunities in the prevention and management of diabetic foot ulcers", Diabetes Care, 41, pp.645~652 (2018)
5. Dascalu, A. M., "In Type 2 Diabetes - From Pathophysiology to Cyber Systems" (2021), IntechOpen
6. Paskal, W., "Single dose of N-Acetylcysteine in local anesthesia increases expression of HIF1α, MAPK1, TGFβ1 and growth factors in rat wound healing", Int. J. Mol. Sci, 22, pp.8659~ (2021)
7. Gabryelska, A., "HIF-1alpha as a mediator of insulin resistance, T2DM, and its complications : potential links with obstructive sleep apnea", Front. Physiol, 11, pp.1035~ (2020)
8. Gao, Y., "LRG1 promotes keratinocyte migration and wound repair through regulation of HIF-1α stability", J. Investig. Dermatol, 140, pp.455~464 (2020)
9. Zurlo, G., "New insights into protein hydroxylation and its important role in human diseases", Biochim. Biophys. Acta Rev. Cancer, 1866, pp.208~220 (2016)
10. Provenzano, R., "Oral hypoxia–inducible factor prolyl hydroxylase inhibitor roxadustat(FG-4592)for the treatment of anemia in patients with CKD", Clin. J. Am. Soc. Nephrol, 11, pp.982~991 (2016)
11. Schodel, J., "Mechanisms of hypoxia signalling: new implications for nephrology", Nat. Rev. Nephrol, 15, pp.641~659 (2019)
12. Haase, V. H., "HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism", Hemodial. Int, 21, pp.S110~S124 (2017)
13. Frost, J., "Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition", Nat. Commun, 7, pp.13312~ (2016)
14. Qiu, S., "Von Hippel-Lindau (VHL) protein antagonist, VH298, promotes functional activities of tendon-derived stem cells and accelerates healing of entheses in rats by inhibiting ubiquitination of hydroxy-HIF-1α", Biochem. Biophys. Res. Commun, 505, pp.1063~1069 (2018)
15. Qiu, S., "Von Hippel-Lindau(VHL)protein antagonist VH298 improves wound healing in streptozotocin-induced hyperglycaemic rats by activating hypoxiainducible factor-(HIF-)1 signalling", J. Diabetes Res, 2019, pp.1897174~ (2019)
16. Li, G., "A small molecule HIF-1α stabilizer that accelerates diabetic wound healing", Nat. Commun, 12, pp.3363~ (2021)
17. Catrina, S. -B., "Hyperglycemia regulates hypoxia-inducible factor-1α protein stability and function", Diabetes, 53, pp.3226~3232 (2004)
18. Dina Johar, "Protein networks linking Warburg and reverse Warburg effects to cancer cell metabolism", BioFactors, 47(5), pp.713~728 (2021), Wiley[DOI]
19. Chokpaisarn, J., "Quercus infectoria inhibits Set7", NF-κB inflammatory pathway in macrophages exposed to a diabetic environment, 2017, pp.94, 29~36
20. Sharma, N., "Role of SET7", 9 in the progression of ischemic renal injury in diabetic and non-diabetic rats, 2020, pp.528, 14~20
21. Natarajan, R., "Epigenetic mechanisms in diabetic vascular complications and metabolic memory : the 2020 Edwin Bierman award lecture", Diabetes, 70, pp.328~337 (2021)
22. Karimnia, N., "Current perspectives in Set7 mediated stem cell differentiation", Noncoding RNA, 2, pp.14~ (2016)
23. Khullar, M., "Emerging evidence of epigenetic modifications in vascular complication of diabetes", Front. Endocrinol, 8, pp.237~ (2017)
24. Lopez-Diez, R., "Diabetes and cardiovascular complications : the epidemics continue", Curr. Cardiol. Rep, 23, pp.1~11 (2021)
25. Luo, W., "Epigenetic regulators : multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity", Cell. Mol. Life Sci, 75, pp.1043~1056 (2018)
26. Koyasu, S., "Regulatory mechanisms of hypoxia-inducible factor 1 activity : two decades of knowledge", Cancer Sci, 109, pp.560~571 (2018)
27. Niwa, H., "Structures of histone methyltransferase SET7", 9 in complexes with adenosylmethionine derivatives, 2013, pp.69, 595~602
28. Sasaki, K., "Inhibition of set domain–containing lysine methyltransferase 7", 9ameliorates renal fibrosis, 2016, pp.27, 203~215
29. Barsyte-Lovejoy, D., "(R)-PFI-2 is a potent and selective inhibitor of SETD7methyltransferase activity in cells", Proc. Natl Acad. Sci. USA, 111, pp.12853~12858 (2014)
30. Verma, S. K., "Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2", ACS Med. Chem. Lett, 3, pp.1091~1096 (2012)
31. Meng, F., "Discovery and optimization of novel, selective histone methyltransferase SET7 inhibitors by pharmacophore-and docking-based virtual screening", J. Med. Chem, 58, pp.8166~8181 (2015)
32. Kashyap, S., "Using ‘biasedprivileged’scaffolds to identify lysine methyltransferase inhibitors", Bioorg. Med. Chem, 22, pp.2253~2260 (2014)
33. Li, G., "A bioactive ligand-conjugated iridium(III)metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury", Redox Biol, 48, pp.102129~ (2021)
34. Chen, J. C., "Investigation of inducing apoptosis in human lung cancer A549cells and related mechanism of a ruthenium(II)polypyridyl complex", Inorg. Chem. Commun, 69, pp.35~39 (2016)
35. Ma, D. -L., "Transition metal complexes as imaging or therapeutic agents for neurodegenerative diseases", J. Mater. Chem. B, 8, pp.4715~4725 (2020)
36. Guodong Li, "Drug screening strategies using metal-based luminescent probes", TrAC Trends in Analytical Chemistry, 139, pp.116270~ (2021), Elsevier BV[DOI]
37. Suh, J. -M., "Strategies employing transition metal complexes to modulate amyloid-β aggregation", Inorg. Chem, 58, pp.8~17 (2018)
38. Liu, W., "Orientation-inspired perspective on molecular inhibitor of tau aggregation by curcumin conjugated with ruthenium (II) complex scaffold", J. Phys. Chem. B, 124, pp.2343~2353 (2020)
39. Ott, I., "Metal N-heterocyclic carbene complexes in medicinal chemistry", Adv. Inorg. Chem, 75, pp.121~148 (2020)
40. Zhong, H. -J., "An iridium (III)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent", Chem. Sci, 6, pp.5400~5408 (2015)
41. Sullivan, M. P., "Probing the Paradigm of Promiscuity for N‐Heterocyclic Carbene Complexes and their Protein Adduct Formation", Angew. Chem. Int. Ed, 60, pp.19928~19932 (2021)
42. Liu, X., "Methyltransferase Set7", 9 regulates p53 activity by interacting with Sirtuin 1(SIRT1), 2011, pp.108, 1925~1930
43. Li, G., "Aurone derivatives as Vps34 inhibitors that modulate autophagy", Acta Pharm. Sin. B, 9, pp.537~544 (2019)
44. Wall, B. J., "Importance of hydrogen bonding: structure–activity relationships of ruthenium (III) complexes with pyridine-based ligands for alzheimer’s disease therapy", J. Med. Chem, 64, pp.10124~10138 (2021)
45. Jain, S. K., "Vitamin D and L-cysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients", Eur. J. Clin. Nutr, 68, pp.1148~1153 (2014)
46. Kanikarla-Marie, P., "Hyperglycemia(high-glucose)decreases L-cysteine and glutathione levels in cultured monocytes and blood of Zucker diabetic rats", Mol. Cell. Biochem, 459, pp.151~156 (2019)
47. Lei, X. W., "Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis", Diabetol. Metab. Syndr, 10, pp.1~8 (2018)
48. Chao, D. B., "Aggregation enhanced luminescent detection of homocysteine in water with terpyridine-based Cu2+ complexes", Sens. Actuators B Chem, 245, pp.146~155 (2017)
49. Qian, C., "SET domain protein lysine methyltransferases : structure, specificity and catalysis", Cell. Mol. Life Sci, 63, pp.2755~2763 (2006)
50. Saito, R., "Characterizations of three major cysteine sensors of keap1 in stress response", Mol. Cell. Biol, 36, pp.271~284 (2016)
51. Wang, K., "The role of cysteines in the structure and function of OGG1", J. Biol. Chem, 296, pp.100093~ (2021)
52. Okabe, J., "Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells", Circ. Res, 110, pp.1067~1076 (2012)
53. Wu, X., "Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis", Redox Biol, 20, pp.46~59 (2019)
54. Kim, Y., "Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis", Nat. Commun, 7, pp.10347~ (2016)
55. Ma, Z., "Targeting hypoxia-inducible factor-1, for cancer treatment : Recent advances in developing small-molecule inhibitors from natural compounds", Semin. Cancer Biol, 80, pp.379~390 (2022)
56. Goggins, B. J., "Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function", Am. J. Physiol. Gastrointest. Liver Physiol, 320, pp.G420~G438 (2021)
57. Sun, J., "HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis", Stem Cell Res, 11, pp.1~13 (2020)
58. Sutthammikorn, N., "Topical gynura procumbens as a novel therapeutic improves wound healing in diabetic mice", Plants, 10, pp.1122~ (2021)
59. Catrina, S. -B., "Hypoxia and hypoxia-inducible factors in diabetes and its complications", Diabetologia, 64, pp.709~716 (2021)
60. Schönborn, M., "Pro-and anti-angiogenic factors: their relevance in diabetic foot syndrome—a review", Angiology, 73, pp.299~311 (2021)
61. Zhang, H., "Epigenetics variation and pathogenesis in diabetes", Curr. Diab. Rep, 18, pp.121~ (2018)
62. Xu, C., "Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis", Diagn. Pathol, 9, pp.1~9 (2014)
63. Boykin, J. V., "Wound nitric oxide bioactivity: a promising diagnostic indicator for diabetic foot ulcer management", J. Wound Ostomy Cont. Nurs, 37, pp.25~32 (2010)
64. Bao, P., "The role of vascular endothelial growth factor in wound healing", J. Surg. Res, 153, pp.347~358 (2009)
65. Bitto, A., "Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes", Pharmacol. Res, 57, pp.159~169 (2008)
66. Galeano, M., "Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse", Diabetes, 53, pp.2509~2517 (2004)
67. Ahluwalia, A., "Critical role of hypoxia sensor-HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing", Curr. Med. Chem, 19, pp.90~97 (2012)
68. Lu, Y. -Y., "Glut-1 enhances glycolysis, oxidative stress, and fibroblast proliferation in keloid", Life, 11, pp.505~ (2021)

관련 논문AI추천